| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 143,455 | 99,941 | 183,167 | 161,265 | | Cost of Revenue | 173,319 | 46,019 | 51,819 | 69,279 | | | Gross Profit | (29,864) | 53,922 | 131,348 | 91,986 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,993 | 17,395 | 20,578 | 18,286 | | Non Recurring | (10,425) | 10,512 | 122 | 4,451 | | Others | (72,756) | 35,399 | 37,357 | 81,493 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 43,324 | (9,384) | 73,291 | (12,244) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 172 | | Earnings Before Interest And Taxes | 43,324 | (9,384) | 73,291 | (12,072) | | Interest Expense | 14,562 | 10,589 | 10,050 | 9,765 | | Income Before Tax | 28,762 | (19,973) | 63,241 | (21,837) | | Income Tax Expense | 10,423 | (7,204) | 21,462 | (9,846) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,339 | (12,769) | 41,779 | (11,991) | | | Non-recurring Events | | Discontinued Operations | 668 | (210) | (6,781) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,007 | (12,979) | 34,998 | (11,991) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,007 | ($12,979) | $34,998 | ($11,991) |
|
0.51% Nasdaq 
Income Statement
